MAMMOMAT Revelation
See the difference. Make the difference.

MAMMOMAT Revelation
Download TiCEM Whitepaper

There are moments in a woman’s life that have the power to change its future course. In mammography, seeing the difference can make the difference to this future. Your patients put their trust in you – reveal all that matters with the new MAMMOMAT Revelation.

Advance screening and diagnostic results – with high diagnostic accuracy

Efficiently make confident decisions using our unique 50° wide-angle tomosynthesis combined with the latest technological trends.

Make the invisible visible
Make all anatomical details clearly visible with the highest depth resolution1 using our unique 50° wide-angle technology – in HD Breast Tomosynthesis2 and HD Breast Biopsy2.

Standardize image quality
Get high-quality breast images every time for each patient, with the intelligent algorithms for automated parameter settings as well as unique system-guided compression.

Get more than just another view
Gain more insight with the first synthetic visualization of tomosynthesis volumes in both 2D and 3D. Get the real 3D2 feeling with our unique Insight 3D: It speeds up your tomo reading and supports easier analysis of microcalcifications at a glance3.

Rely on exact density assessment
Visual classification of breast density can be challenging. With Insight Breast Density2 you can be sure: It offers 100% objective, volumetric classification for instant risk stratification right at the acquisition workstation.

Elevate patient experience – with smart automation

Offer a relaxing atmosphere: smart automation and the unique MoodLight2 help soothe anxiety and put patients at ease.

Personalize compression for optimal results
Reduce patient discomfort and achieve consistent breast image quality with Personalized Soft Compression2: The optimal compression is automatically adjusted for each woman.

Enhance patient comfort
Having soft edges and a breast-optimized shape, our SoftComp Paddles2 allow for easy positioning and offer high comfort.

Reduce unnecessary steps
Our one-click philosophy: select the patient and start the examination with one click. All parameters are set automatically and the procedure moves from step to step.


Innovate care delivery – designed for excellence today and tomorrow

A safe investment: adapt MAMMOMAT Revelation any time to match your clinical needs – and offer patients personalized care.

Offer your patients certainty
Excellent imaging for diagnostic accuracy: our 50° wide-angle tomosynthesis has shown a 41.5% higher cancer detection rate for invasive cancer4 with 1-view tomo only5

Attract more women for screening
Ease pain by reducing compression force by up to 50%4 in tomo. And offer patients low-dose examinations with up to 30% less dose6 in 2D with PRIME.

Streamline your clinical workflow
With intuitive one-click targeting in HD Breast Biopsy2 and the integrated specimen scanner InSpect2 you speed up your biopsy workflow.

Stay at the forefront of clinical developments
Get additional diagnostic information fast with our Titanium Contrast Enhanced Mammography (TiCEM)2, a cost-effective alternative to MRI as an adjunct examination.

Related Products, Services & Resources

1Maldera et al. (2016): Digital breast tomosynthesis: Dose and image quality assessment. Physica Medica, pp. 1-12.; Marshall N.W. and Bosmans H. (2012): Measurements of system sharpness for two digital breast tomosynthesis systems. Phys. Med. Biol. 57, pp. 7629-7650.; Rodríguez-Ruiz A. et al. (2016): Evaluation of the technical performance of three different commercial digital breast tomosynthesis systems in the clinical environment. Physica Medica 32, pp. 767-777.


3Uchiyama N. et al. (2016): Diagnostic Usefulness of Synthetic MMG (SMMG) with DBT (Digital Breast tomosynthesis) for Clinical – Setting in Breast Cancer Screening. Springer International Publishing Switzerland. IWDM 2016, LNCS 9699, pp. 59–67.

4Lång K. et al. (2016): Performance of one-view breast tomosynthesis as a stand-alone breast cancer screening modality: results from the Malmö BreastTomosynthesis Screening Trial, a population-based study. Eur Radiol 26, pp. 184-190. (Please note: Final result will be presented at RSNA 2017)

5“1-view tomo only” is not FDA approved in the U.S.

6Compared to grid-based acquisition with Mammomat Inspiration, depending on breast thickness - L.B. Larsen, A. Fieselmann, H. Pfaff, T. Mertelmeier Performance of grid-less digital mammography acquisition technique for breast screening: analysis of 22,117 examinations Presentation B-1025 ECR 2015

MAMMOMAT Revelation is not commercially available in all countries. Due to regulatory reasons its future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.